United Kingdom · Question · Written question
UIN 184142
Phenytoin
Original
Introduced
9 May 2023
Last action
16 May 2023 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
16 May 2023
Summary
To ask the Secretary of State for Health and Social Care, with reference to the Competition and Markets Authority finding in 2022 that Pfizer and Flynn charged the NHS unfairly high prices for phenytoin sodium capsules for over four years, what steps his
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
9 May 2023
Written question
To ask the Secretary of State for Health and Social Care, with reference to the Competition and Markets Authority finding in 2022 that Pfizer and Flynn charged the NHS unfairly high prices for phenytoin sodium capsules for over four years, what steps his
Source: Commons
16 May 2023
Answer
The United Kingdom has well established systems for controlling costs and ensuring we get value for money for spending on medicines. For unbranded generic medicines the Department relies on competition to keep prices down. This has led to some of the lowe...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2023-05-09/184142
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1626151
- uk · wq-1626151 · source updated 16 May 2023